Super-stop Bloodclotter Aerosol, Spray
NDC Package 42961-223-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Super-stop Bloodclotter (blood clotter) aerosols is shake can well before usinghold 6-8 inches from moist injured areaspray until area is coveredscab-like cover will gradually disappear as healing takes place or may be removed with soap and waterfor adult institutional use onlynot intended for use on children. This formulation utilizes a aerosol, spray delivery system. Marketed by Cintas Corp, this product is identified by NDC 42961-223 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
42961-223-01
Package Description
85000 mg in 1 CAN
Product Code
42961-223
11-Digit Billing Format
42961022301
RxNorm Crosswalk
  • RxCUI: 1545716 - benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray
  • RxCUI: 1545716 - benzethonium chloride 2 MG/ML / lidocaine 40 MG/ML Topical Spray

Clinical Specifications

Proprietary Name
Super-stop Bloodclotter
Non-Proprietary Name
Blood Clotter
Substance Name
Benzethonium Chloride; Lidocaine
Dosage Form
Aerosol, Spray - An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Shake can well before usinghold 6-8 inches from moist injured areaspray until area is coveredscab-like cover will gradually disappear as healing takes place or may be removed with soap and waterfor adult institutional use onlynot intended for use on children

Regulatory & Marketing

Labeler Name
Cintas Corp
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-28-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42961-223-01 identifies a specific commercial package of 85000 mg in 1 can of Super-stop Bloodclotter, a human over the counter drug labeled by Cintas Corp. This aerosol, spray is formulated for topical use and contains benzethonium chloride; lidocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cintas Corp on March 28, 2022. The current certification is valid through December 31, 2026.

How is this Cintas Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42961022301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42961-223-01
11-Digit CMS (5-4-2)
42961-0223-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.